SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
September 1, 1998
Date of Report (Date of earliest event reported)
D-LANZ DEVELOPMENT GROUP, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-5367 11-1717709
(State or other jur- (Commission (IRS Employer
isdiction of incor- File Number) Identification No.)
poration)
400 GROVE STREET, GLEN ROCK, NJ 07452
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (201) 457-1221
(Former name or former address, if changed since last report.) No change.
<PAGE>
Item 1. Change in Control of Registrant
Not applicable.
Item 2. Acquisition of Assets
Not applicable.
Item 3. Bankruptcy or Receivership
Not applicable.
Item 4. Changes in Registrant's Certifying Public Accountant.
Not applicable.
Item 5. Other events.
The company has entered into a distribution agreement with Sandell
Corp. S.A. to distribute its medical device in Chile, attached hereto as
Exhibit 1. Through its merger with HTI, the Company had previously acquired
the licensed distribution rights of the device in the countries of Chile
and Singapore from Scantek Medical, Inc. of Denville, New Jersey. This
information is available on the Company's form 8k submitted in December,
1997, incorporated herein by reference.
Item 6. Resignations of Registrant's Directors
Not applicable.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Not Applicable
Item 8. Change in Fiscal Year
Not applicable
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has caused this report to be signed on its behalf the
undersigned hereunto duly authorized.
Date: September 23, 1998
D-LANZ DEVELOPMENT GROUP, INC.
BY:__/s/Roger Fidler______
Roger L. Fidler
President
<PAGE>
EXHIBIT 1
Sandell S.A.
Joaquinto Requena, No. 1167
C.P. 11.200
Montevideo, Uruguay
Roger L. Fidler
President
D-Lanz Development Group, Inc.
400 Grove St.
Glen Rock, New Jersey 07452
USA
Re: Distribution Agreement
Dear Mr. Fidler:
This letter agreement confirms our agreement that Sandell Corp. S.A. will effect
distribution of the BreastCare medical device in Chile. The purchase price to
Sandell will be $8.30 per unit. The BreastCare units will be suppied to Sandell
by Scantek Medical, S.A. from its assemble facility in Montevideo in behalf of
D-Lanz. The minimum number of units to be purchased will be negotiated in good
faith in the near future and such a minimum will be required to effect
exclusivity.
If the above also constitutes your understanding of our agreement please
countersign below.
Yours truly,
/s/ Daniel Alvarez
Daniel Alvarez
President
Reviewed, Accepted and agreed to on
This 19th day of August, 1998
D-LANZ DEVELOPMENT GROUP, INC.
BY: /s/ Roger L. Fidler
Roger L. Fidler
President
<PAGE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from
financial statements for the nine month period ended September 30, 1997 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-END> SEP-30-1998
<CASH> 2,000
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 2,000
<PP&E> 0
<DEPRECIATION> (41,934)
<TOTAL-ASSETS> 0
<CURRENT-LIABILITIES> 0
<BONDS> 0
0
1
<COMMON> 10,000
<OTHER-SE> 246,051
<TOTAL-LIABILITY-AND-EQUITY> 254,500
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 0
<EPS-PRIMARY> .00
<EPS-DILUTED> .00
</TABLE>
